Focus on: Non-Muscle Invasive Bladder Cancer Update for the Urology Care Team

New for 2026, AUA2026 Focus on: are series of accredited sessions, offering an in-depth exploration of key clinical topics aligned with AUA’s ongoing needs assessments. The format allows for a deeper dive into each topic, exploring clinical advances, reviewing the latest evidence-based guidelines and discussing application into clinical practice. Focus on: Non-Muscle Invasive Bladder Cancer Update for the Urology Care Team will offer education and updates to the urology care team on the complex management of bladder cancer patients and the latest advancements in NMIBC.

Learning Objectives:
After participating in this CME activity, participants will be able to:
1. Analyze emerging data in NMIBC and guideline updates to evaluate the impact of disease recurrence and treatment-related complications on current care pathways and patient outcomes.
2. Apply guideline-driven risk stratification in order to identify and select appropriate patients with high-risk NMIBC for optimal therapy sequencing and escalation of care.
3. Implement strategies for safe and effective integration of novel intravesical and systemic immunotherapies to strengthen multidisciplinary collaboration and shared decision-making between urology and medical oncology.
4. Develop patient-centered, evidence-informed care plans using guideline updates and real-world case examples, in order to address unmet needs, reduce recurrence risk, and improve quality of life for patients with NMIBC